|
(Health-NewsWire.Net, November 18, 2021 ) The outbreak of COVID-19 has led to an increase in the preference for remote monitoring. The crisis has ushered in a new era in the hearing healthcare space that requires a radical rethinking of service delivery in audiology. Low- and no-touch services are now necessary for audiology patients (who are typically at the highest risk for COVID-19 morbidity and mortality due to their advanced age). Also, hearing aid manufacturers have started focusing on including mobile audiometry and digital hearing care solutions for remote hearing aid device troubleshooting, counseling, fine-tuning, and tracking.
Globally, the rising incidence of hearing loss has made it extremely important to monitor and examine hearing functions. In children, untreated hearing loss negatively impacts language development, learning, and social engagement.
This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the hearing aids market to focus on emerging countries.
The high cost of hearing aids, such as cochlear implants and bone-anchored systems, is a major factor restraining the market growth, particularly in price-sensitive regions such as the Asia Pacific, Latin America, and Africa. Healthcare providers, especially in developing countries such as Brazil and Mexico, have low financial resources to invest in sophisticated technologies.
Download PDF Brochure With Latest Edition @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198630754
Currently, several countries are facing a shortage of skilled professionals who are capable of effectively performing ENT procedures, such as cochlear implantation. Underdeveloped countries and regions face this problem on a much wider scale. The dearth of skilled ENT surgeons in these countries is expected to limit the number of ENT procedures performed, including cochlear implantation, carried out per year despite the presence of a large target patient population base. This is a major challenge for the growth of the hearing aids market.
The hearing aids market is segmented into hearing aid devices and hearing implants based on product. The hearing aid devices segment accounted for the largest share of the hearing aids market in 2020, mainly due to the increasing technological advancements in hearing aid devices and the increasing number of product approvals.
The hearing aids market is segmented into adults and pediatrics based on patient type. In 2020, the adult patients segment accounted for the largest share of the hearing aids market. The growing incidence of hearing loss among the adult population is driving the growth of this segment.
To get a free sample report, Click here: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198630754
The global hearing aids market is segmented into five major regions — North America, Europe, the Asia Pacific, Latin America, and the Middle East Africa. In 2020, Europe accounted for the largest share of the hearing aids market. The European hearing aids market’s growth can be attributed to the well-established healthcare industry, the increasing incidence of hearing disorders, and the rapid adoption of technologically advanced hearing aids.
Some key players in the hearing aids market (2021- 2026)
Sonova Group (Switzerland)
Demant A/S (Denmark)
GN Store Nord A/S (Denmark)
Cochlear Ltd. (Australia)
RION Co., Ltd. (Japan)
#Hearing Aids Market #Hearing Aids #Hearing #AIDS #health #Healthcare
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
